Table 4 Characteristics of distant recurrence cases in the study cohort.

#

Age at 1^st testing, years

Nodal status at 1^st testing

RS, 1^st testing

Surgery

Treatment received after first testing

Duration between ET discontinuation and 2^nd testing

Duration between 1^st and 2^nd testing, years

RS, 2^nd testing

Ipsilateral/ contralateral BC

Treatment received after 2^nd testing

Duration between 2^nd testing and metastatic disease, years